Do not stop or change your medication without speaking to a pharmacist or healthcare professional.

This is a historical report — it no longer reflects this drug's current status. Current status: Permanently Discontinued. View this drug's full profile page →

Active Shortage

ACT LATANOPROST/TIMOLOL

TEVA CANADA LIMITED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is ACT LATANOPROST/TIMOLOL discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that ACT LATANOPROST/TIMOLOL 5MG 50MCG has been permanently discontinued (last updated October 27, 2026). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is ACT LATANOPROST/TIMOLOL not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Check with your pharmacist
StatusActive Shortage
Same-ingredient products on fileNone found
Affected strength5MG 50MCG
Report last updated2022-08-18
Checked by MedShort2026-11-13

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02436256

Strength

5MG 50MCG

Dosage Form

SOLUTION

Route

OPHTHALMIC

Active Ingredient

TIMOLOL LATANOPROST

Tier

Unrated

Last Updated

2022-08-18

Reason for Shortage

Disruption of the manufacture of the drug.

Past Reports for This Drug

ACT LATANOPROST/TIMOLOL has 2 shortage/discontinuation reports on file — this is one of them.